ArchivesMagazine - 22 Jul 2021International Biotech looks for M&A booster shot Company’s underperformance linked to restrictions on investing in vaccine stocks 22 July 2021|Investment Trusts|by Martin Gamble Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email < The case for making the big pension switch Issue: 22 Jul 2021 - Page 30 | Contents Previous: The case for making the big pension switch Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. Share on Facebook Share on Bluesky Share on X (Twitter) Share by Email Martin Gamble Issue Contents Ask Tom Will I benefit from the triple-lock? Editor's View Why Freedom Day has been such a dud on the markets Feature UK stocks: Cheap and finally on investors’ radar Why you would invest in a fund which aims not to lose cash Can Dignity ever reclaim its defensive qualities? Great Ideas Guard against uncertainty with Guinness Global Equity Income Frontier Developments is a UK gaming star Hipgnosis could benefit from reset of streaming economics The small cap stock that continues to smash forecasts Find out what’s powered a 25% gain in Biffa Investment Trusts International Biotech looks for M&A booster shot News Stagflation fears trip up global stock markets Airline shares dive as summer earnings expectations decline Market leadership narrows as investors take to sidelines Personal Finance The case for making the big pension switch Russ Mould Why Chinese stocks are still not partying Under The Bonnet Why Lotus Bakeries’ Biscoff could be the next Oreo
